Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation

ConclusionChemoprevention may be an effective risk-reduction option forBRCA mutation carriers, but further studies with longer follow-up are necessary.

Source: Breast Cancer Research and Treatment - July 22, 2023 Category: Cancer & Oncology Source Type: research